Former Arizona Cardinals running back Chris Johnson says he has been diagnosed with ALS

Chris Johnson, the former Arizona Cardinals running back best known for his rare combination of power and acceleration, disclosed that he has been diagnosed with ALS. The announcement comes as Johnson, long associated with the NFL’s most explosive rushing styles, transitions from life as a player into a new and difficult personal chapter shaped by a progressive neurological illness.

According to the report, Johnson “arrived in Tempe” after establishing himself in the league and later played his final three NFL seasons with the Cardinals. For Cardinals fans, that timeframe matters because it places the final stretch of Johnson’s career in the modern era of the franchise, when the team was building identities around speed, pace, and offensive schemes designed to create yards in chunks.

The diagnosis, ALS, is a disease that progressively affects motor neurons, leading to worsening control of voluntary muscles. While the NFL playing career is often defined by statistics, Johnson’s disclosure shifts the focus to his health and the support systems that athletes typically rely on after retirement, including medical care, family resources, and community fundraising or awareness efforts that frequently follow major diagnoses in professional sports.

Johnson’s name is tightly linked with the era when elite rushing talents could completely change the rhythm of a game in a few seconds. In that context, the public details of his illness underline an important reality for sports followers: careers built on physical performance do not end when the jersey comes off. Instead, former players continue to face serious medical and quality-of-life questions, even years after retirement.

Arizona’s connection to Johnson makes the news more than a standalone personal update. The Cardinals have repeatedly emphasized the importance of their alumni and the long-term relationship they maintain with former players, even as the roster turns over quickly each offseason. When a former star reveals a life-altering diagnosis, the conversation inevitably spreads to how teams, leagues, and fans can provide practical support beyond public sympathy.

For the NFL at large, the announcement also serves as another reminder of the human side of a league defined by competition and contact. ALS remains incurable, and the diagnosis raises the stakes for awareness, research, and patient support. In many sports communities, a notable former player’s disclosure becomes a catalyst for renewed fundraising and educational campaigns aimed at improving early detection and care options.

Johnson’s next steps are not specified in the report, and there is no additional confirmed information here about treatment plans or timelines. What is clear is that his disclosure will likely draw attention from NFL alumni networks and Cardinals supporters, and it may also encourage other former players and public figures to speak about neurological disease, a subject that is often delayed until a crisis forces the conversation.